Lim Bryant David - Insider Non-Derivative Transactions at IDERA PHARMACEUTICALS, INC. (IDRA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 6, 2023, Lim Bryant David's relationship to IDERA PHARMACEUTICALS, INC. (IDRA) is Officer (SVP AND GENERAL COUNSEL), and currently has 429,652 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other IDRA insiders.
Data Source: SEC.
Lim Bryant David - Insider Non-Derivative Transactions at IDRA
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Jan 7, 2023 | F -- (Common Stock) | 119957 | 0.71 | 309695 |
Jan 7, 2023 | Acquisition -- (Common Stock) | 399218 | 0 | 429652 |